Nuzenio

Tradingview Irwd

Tradingview Irwd entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

IRWD: Strong revenue and profit growth fueled by LINZESS, with key pipeline and financial milestones achieved - TradingViewTradingView · Thu, 06 Aug 2026 20:09:18 GMTIRWD: LINZESS sales surged and guidance was raised as apraglutide advanced in phase III trials - TradingViewTradingView · Thu, 06 Aug 2026 14:04:41 GMTIRWD: Q2 2026 net sales surged 44% year-over-year, prompting raised full-year guidance - TradingViewTradingView · Thu, 06 Aug 2026 12:31:44 GMTIRWD: Raised 2026 guidance after robust Q2 LINZESS sales, margin gains, and debt repayment - TradingViewTradingView · Thu, 06 Aug 2026 12:28:28 GMTIronwood Raises 2026 Guidance After Q2: Revenue $113M, GAAP Net Income $51M, Adjusted EBITDA $83M - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTBRIEF-Ironwood Pharmaceuticals Q2 Revenue USD 113.041 Million Vs. IBES Estimate USD 114.8 Million - TradingViewTradingView · Thu, 06 Aug 2026 11:06:00 GMTIRWD Q2'26 Earnings: EPS estimate is 0.32 USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:24 GMTIRWD Q2'26 Earnings: revenue estimate is 114.84M USD - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 20:09:18 GMTIRWD: Strong revenue and profit growth fueled by LINZESS, with key pipeline and financial milestones achieved - TradingView
Thu, 06 Aug 2026 14:04:41 GMTIRWD: LINZESS sales surged and guidance was raised as apraglutide advanced in phase III trials - TradingView
Thu, 06 Aug 2026 12:31:44 GMTIRWD: Q2 2026 net sales surged 44% year-over-year, prompting raised full-year guidance - TradingView
Thu, 06 Aug 2026 12:28:28 GMTIRWD: Raised 2026 guidance after robust Q2 LINZESS sales, margin gains, and debt repayment - TradingView
Thu, 06 Aug 2026 11:13:01 GMTIronwood Raises 2026 Guidance After Q2: Revenue $113M, GAAP Net Income $51M, Adjusted EBITDA $83M - TradingView
Thu, 06 Aug 2026 11:06:00 GMTBRIEF-Ironwood Pharmaceuticals Q2 Revenue USD 113.041 Million Vs. IBES Estimate USD 114.8 Million - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Irwd.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.